Skip to main content

Table 2 Spearman correlations between RV-arterial coupling parameters and other parameters of RV function and metabolism

From: Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension

 

RV GLS/PASP

RV GLS/PVR

RV GLS*PAC

WHO class

r = 0.28; p = 0.15

r = 0.28; p = 0.14

r = 0.26; p = 0.19

6MWT distance

r = − 0.22; p = 0.25

r = − 0.29; p = 0.13

r = − 0.22; p = 0.24

BNP level

r = 0.31; p = 0.10

r = 0.34; p = 0.07

r = 0.30; p = 0.12

TAPSE (CMR)

r = − 0.15; p = 0.43

r = − 0.15; p = 0.42

r = − 0.08; p = 0.65

RVEF (CMR)

r = − 0.75; p = 0.000005^

r = − 0.71; p = 0.00002^

r = − 0.73; p = 0.00001^

FAC (CMR)

r = − 0.78; p = 0.000002^

r = − 0.77; p = 0.000001^

r = − 0.69; p = 0.00004^

RV mass/BSA (CMR)

r = 0.59; p = 0.001^

r = 0.60; p = 0.0008^

r = 0.47; p = 0.012^

CI (RHC)

r = − 0.54; p = 0.003^

r = − 0.63; p = 0.0004^

r = − 0.48; p = 0.01^

SUVRV/LV (PET)

r = 0.67; p = 0.0002^

r = 0.55; p = 0.002^

r = 0.69; p = 0.00006^

  1. 6MWT six minute walk test distance, BNP serum brain natriuretic peptide, BSA body surface area, CI cardiac index, CMR cardiac magnetic resonance, GLS global longitudinal strain, FAC fractional area change, LV left ventricle, PAC pulmonary arterial compliance, PASP pulmonary artery systolic pressure, PET positron emission tomography, PVR pulmonary vascular resistance, RV right ventricle, RVEF right ventricle ejection fraction, SUV standardized uptake value, TAPSE tricuspid annular plane systolic excursion, WHO World Health Organisation
  2. ^p-value significant (lower than 0.05) after Benjamini–Hochberg correction